60 Degrees Pharmaceuticals
SXTP
9 hedge funds and large institutions have $198K invested in 60 Degrees Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.
378% more capital invested
Capital invested by funds: $41.4K → $198K (+$157K)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
50% more funds holding
Funds holding: 6 → 9 (+3)
0.25% more ownership
Funds ownership: 0.09% → 0.33% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$109K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$18.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$17K |
| 4 |
HF
HRT Financial
New York
|
+$13.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$16K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$12.7K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $128K | +$109K | +4,947 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $26.3K | +$18.8K | +854 | +514% |
|
|
TSS
3
Two Sigma Securities
New York
| $19.9K | +$17K | +772 | New |
|
|
HF
4
HRT Financial
New York
| $16K | +$13.9K | +630 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $4.81K | +$2.49K | +113 | +153% |
|
|
SHF
6
Safe Harbor Fiduciary
Pensacola,
Florida
| $1.77K | – | – | – |
|
|
BWL
7
Bogart Wealth LLC
Mclean,
Virginia
| $903 | +$772 | +35 | New |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $645 | +$552 | +25 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $17 | +$22 | +1 | New |
|
|
VF
10
Virtu Financial
New York
| – | -$16K | -634 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$12.7K | -505 | Closed |
|
|
12
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$5K | -200 | Closed |
|
SXTP Hedge Fund Activity: Q4 2024 in Review
9 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q4 2024, worth a combined $198K — up 378% from $41.4K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SXTP positions and 3 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $109K. The largest seller was Virtu Financial, exiting entirely with an estimated $16K sold.
- 9 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q4 2024, up from 6 in Q3 2024.
- Funds reported $198K of 60 Degrees Pharmaceuticals stock for Q4 2024, up 378% quarter-over-quarter.
- 6 funds opened new 60 Degrees Pharmaceuticals positions in Q4 2024 and 3 closed out, a net change of +3 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q4 2024 was Armistice Capital, an estimated $109K added.
- The largest 60 Degrees Pharmaceuticals seller in Q4 2024 was Virtu Financial, an estimated $16K sold.
Based on aggregated 13F filings for Q4 2024.